India Quarterly Results BSE NSE Announcements — April 27, 2026

To consider and approve the audited financial results for the quarter and financial year ended March 31, 2026 and to recommend dividend, if any, on the equity shares of the Company for the financial year 2025-26.

To consider other business matters

To consider and approve the financial results for the quarter and year ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

The meeting of the Board of Directors of the Bank will be held on Monday, April 27, 2026, to, inter alia, consider and approve the following:1. Audited Financial Results of the Bank for the Quarter and Financial Year ended on March 31, 2026.2. Recommend Dividend on equity shares, if any, for the financial year ended on March 31, 2026.3. Passing an enabling resolution for annual renewal of fund raising limits by way of:a) issuance of equity shares through private placement or qualified institutions placement (QIP) or preferential allotment or through a combination thereof or any other alternative mode, as may be considered appropriate, subject to necessary approvals and requirements, as applicable.b) issuance of debt instruments including but not limited to Bonds and Non-Convertible Debentures or such other debt securities as may be permitted by RBI from time to time, subject to necessary approvals and requirements, as applicable.Please refer attachment for further details.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend and bonus shares if any, subject to approval of shareholders of the bank.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the SEBI Listing Regulations ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 27th April, 2026, inter alia, to consider and approve Audited Financial Results for the quarter and year ended 31st March, 2026 and to recommend final dividend for the Financial Year 2025-26, if any.Accordingly, the Trading Window for dealing in securities of the Company shall remain closed for all Insiders including Designated Person, Connected Person and their immediate relatives from 01st April, 2026 to 29th April, 2026.This is for your information and record.

To consider and approve the proposal for conversion of Inter Corporate Deposits (ICD) granted by the Company to its wholly owned subsidiary Heranba Organics Private Limited ( HOPL ), into Optionally Fully Convertible Debentures (OFCDs) on such terms and conditions as may be approved.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

Nippon Life India Asset Management Ltd has informed that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Audited Financial Results for the quarter and year ending March 31, 2026 and to recommend dividend on equity shares, if any.

To consider other business matters

Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March 2026 and recommendation of Dividend on Equity Shares, if any, for the said year

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

Rossari Biotech Limited has informed NSE that the meeting of Board of Directors of the Company is scheduled on 27/04/2026, inter alia, to consider and approve, 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2026. 2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited financial results for the financial year ended March 31, 2026 and recommendation of dividend, if any

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Audited Standalone and Consolidated financial results for the quarter and financial year ended March 31, 2026.

To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the year ending 31st March, 2026 and recommend dividend, if any, on the equity shares of the Company for the year ending 31st March, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the Quarter and Financial year period ended on March 31, 2026

Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday, April 27, 2026 inter-alia to consider and approve the following:(i) Unaudited Financial Results of the Company, both on Standalone and Consolidated basis, for the Quarter ended March 31, 2026. (ii) Declaration of interim dividend to the Equity Shareholders of the Company for the Financial Year 2026.In continuation to our letter dated March 24, 2026 regarding the closure of Trading Window from April 1, 2026 till 48 hours after public announcement of the Unaudited Financial Results for the Quarter ended March 31, 2026, we wish to inform you that the Trading Window will be closed till April 29, 2026.Further, please note that the Company is following 1st January to 31st December as its Financial Year in terms of Section 2(41) of the Companies Act, 2013 as approved by the Company Law Board.

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters